CA2294705A1 - 19 human secreted proteins - Google Patents

19 human secreted proteins Download PDF

Info

Publication number
CA2294705A1
CA2294705A1 CA002294705A CA2294705A CA2294705A1 CA 2294705 A1 CA2294705 A1 CA 2294705A1 CA 002294705 A CA002294705 A CA 002294705A CA 2294705 A CA2294705 A CA 2294705A CA 2294705 A1 CA2294705 A1 CA 2294705A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
sequence
cells
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002294705A
Other languages
English (en)
French (fr)
Inventor
Kenneth C. Carter
Ping Feng
Craig A. Rosen
Steven M. Ruben
Gregory A. Endress
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2294705A1 publication Critical patent/CA2294705A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002294705A 1997-07-01 1998-06-30 19 human secreted proteins Abandoned CA2294705A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5148097P 1997-07-01 1997-07-01
US5138197P 1997-07-01 1997-07-01
US60/051,480 1997-07-01
US60/051,381 1997-07-01
US5859897P 1997-09-12 1997-09-12
US5866397P 1997-09-12 1997-09-12
US60/058,663 1997-09-12
US60/058,598 1997-09-12
PCT/US1998/013608 WO1999001020A2 (en) 1997-07-01 1998-06-30 19 human secreted proteins

Publications (1)

Publication Number Publication Date
CA2294705A1 true CA2294705A1 (en) 1999-01-14

Family

ID=27489406

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002294705A Abandoned CA2294705A1 (en) 1997-07-01 1998-06-30 19 human secreted proteins

Country Status (5)

Country Link
US (2) US20040024192A1 (ja)
EP (1) EP1009766A4 (ja)
JP (1) JP2002514925A (ja)
CA (1) CA2294705A1 (ja)
WO (1) WO1999001020A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171542A1 (en) * 1997-07-03 2003-09-11 Zymogenetics, Inc. Mammalian secretory peptide - 9
US6949339B1 (en) 1998-05-21 2005-09-27 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
US6623923B1 (en) 1998-12-23 2003-09-23 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1337200A (en) * 1998-11-02 2000-05-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Selective toxicity of amino-terminal modified rnase a superfamily polypeptides
DE69934903T2 (de) 1998-11-10 2007-10-18 Emory University Mitogene regulatoren
US6284241B1 (en) 1998-12-23 2001-09-04 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU2387900A (en) * 1998-12-23 2000-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US20030031670A1 (en) * 1999-11-08 2003-02-13 Jack R. Wands Diagnosis and treatment of malignant neoplasms
US6835370B2 (en) * 1999-11-08 2004-12-28 Rhode Island Hospital Diagnosis and treatment of malignant neoplasms
CA2396036A1 (en) * 1999-12-30 2001-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU2002231077A1 (en) * 2000-12-19 2002-07-01 Glaxo Group Limited Novel compounds
JP2009506773A (ja) * 2005-09-01 2009-02-19 ザ・フェインスタイン・インスティチュート・フォー・メディカル・リサーチ メラノサイト刺激ホルモンペプチド模倣体
WO2011064179A1 (en) * 2009-11-26 2011-06-03 F. Hoffmann-La Roche Ag Marker protein for type 2 diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929033A (en) * 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein

Also Published As

Publication number Publication date
EP1009766A1 (en) 2000-06-21
WO1999001020A2 (en) 1999-01-14
EP1009766A4 (en) 2003-04-09
JP2002514925A (ja) 2002-05-21
US20040024192A1 (en) 2004-02-05
US20060188962A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
CA2295474A1 (en) 123 human secreted proteins
US20060188962A1 (en) 19 human secreted proteins
EP1015477B1 (en) 32 Human secreted proteins
EP1040117A1 (en) 110 human secreted proteins
US6525174B1 (en) Precerebellin-like protein
CA2286303A1 (en) 20 human secreted proteins
US6881823B2 (en) Human protein HFXJW48
CA2294526A1 (en) 86 human secreted proteins
CA2317702A1 (en) 36 human secreted proteins
WO1999011293A1 (en) 50 human secreted proteins
EP1027430A1 (en) 64 human secreted proteins
WO1999024836A1 (en) 125 human secreted proteins
CA2305690A1 (en) 53 human secreted proteins
CA2298852A1 (en) 83 human secreted proteins
EP1017707A1 (en) 29 human secreted proteins
CA2305685A1 (en) 101 human secreted proteins
CA2321970A1 (en) 36 human secreted proteins
US20050214844A1 (en) 86 human secreted proteins
EP1439189A2 (en) 86 Human Secreted Proteins
EP1557425A2 (en) 123 human secreted proteins
EP1346999A2 (en) Human secreted protein
EP1428833A2 (en) 207 human secreted proteins
EP1464653A1 (en) Human secreted proteinteins
EP1439224A2 (en) 67 human secreted proteins
EP1445316A1 (en) Novel secreted protein

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued